The treatment of breast cancer has been developed from the initial surgical method on local area control to multidisciplinary management, focusing on systemic treatment, thus significantly improving survival rates.27 However, the response of breast cancer patients to chemotherapy is very different, despite the initial clinical response, patients developed a certain degree of resistance.28 In our study, CDR1as was found to be highly expressed in 90 breast cancer patients. The gene discussed is LINC00632; the disease is breast carcinoma.